These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration. Yau GL; Campbell RJ; Li C; Sharma S Can J Ophthalmol; 2015 Oct; 50(5):345-9. PubMed ID: 26455968 [TBL] [Abstract][Full Text] [Related]
5. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration. Beck M; Munk MR; Ebneter A; Wolf S; Zinkernagel MS Am J Ophthalmol; 2016 Jul; 167():10-7. PubMed ID: 27084000 [TBL] [Abstract][Full Text] [Related]
6. Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD. Creer R; Boonarpha N; Gould G; Rajai A; Chhabra R Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2411-2419. PubMed ID: 38446199 [TBL] [Abstract][Full Text] [Related]
7. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration. Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772 [No Abstract] [Full Text] [Related]
8. Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration. Ranjbar M; Kurz M; Holzhey A; Rades D; Grisanti S Ophthalmic Surg Lasers Imaging Retina; 2018 May; 49(5):320-328. PubMed ID: 29772042 [TBL] [Abstract][Full Text] [Related]
15. Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients. Kim SY; Yoon MH; Chin HS Korean J Ophthalmol; 2020 Feb; 34(1):11-18. PubMed ID: 32037745 [TBL] [Abstract][Full Text] [Related]
16. Retinal Nerve Fiber Loss in Anti-VEGF Therapy for Age-Related Macular Degeneration Can Be Decreased by Anterior Chamber Paracentesis. Enders P; Sitnilska V; Altay L; Schaub F; Muether PS; Fauser S Ophthalmologica; 2017; 237(2):111-118. PubMed ID: 28245446 [TBL] [Abstract][Full Text] [Related]
17. Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition. Lee WJ; Kim YK; Kim YW; Jeoung JW; Kim SH; Heo JW; Yu HG; Park KH J Glaucoma; 2017 Nov; 26(11):980-986. PubMed ID: 28930884 [TBL] [Abstract][Full Text] [Related]
18. Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular Degeneration. Wang L; Swaminathan SS; Yang J; Barikian A; Shi Y; Shen M; Jiang X; Feuer W; Gregori G; Rosenfeld PJ Ophthalmol Retina; 2021 Jul; 5(7):648-654. PubMed ID: 33045458 [TBL] [Abstract][Full Text] [Related]
19. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Lee H; Ji B; Chung H; Kim HC Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214 [TBL] [Abstract][Full Text] [Related]
20. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]